Predictive Health Diagnostics

About Predictive Health Diagnostics

Predictive Health Diagnostics Co. (PH Diagnostics) specializes in providing advanced diagnostic solutions to clients in the biotechnology, pharmaceutical, and cancer diagnostic testing sectors. Operating on a global scale, the company adheres to industry best practices, including Good Laboratory Practice (GLP) and Good Distribution Practice (GDP), and conforms to ISO 15189 standards, ensuring high-quality and reliable results. PH Diagnostics offers a range of services, including COVID-19 antibody testing and comprehensive clinical trial services through its CLIA-accredited laboratory. The company's business model revolves around partnering with leading healthcare technology developers to innovate and improve medical diagnostics. Revenue is generated through service contracts with biotechnology firms, pharmaceutical companies, and research institutions. With over 40 years of experience in clinical trials and reference laboratory testing, PH Diagnostics aims to proactively intervene and prevent disease through strategic planning and expert analysis.